RMD Filing
4Filing Date: Feb 6, 2026
RESMED INC (RMD) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0000943819-26-000009open_in_new
Total Value$13.0K
Trades1
Insiders1
Transaction Details
Rider Michael J
Global General Counsel·Direct
Sell · Dispose
ResMed Common Stock
Shares-50
Price$260.00
Total Value$13.0K
Shares Owned After9.69K
Transaction DateFeb 4, 2026
10b5-1
Footnotes ▸
The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
Post-Transaction Holdings
Rider Michael J
| Security | Shares | Change |
|---|---|---|
| ResMed Common Stock | 9.69K | -50 (-0.51%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-02-04
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: RESMED INC (RMD)
CIK: 0000943819
--- Reporting Owner ---
Name: Rider Michael J
CIK: 0001982205
Role: Officer (Global General Counsel)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: ResMed Common Stock
Date: 2026-02-04 | Code: S (Open market sale)
Shares: -50 | Price: $260.00
Total Value: $13,000.00
Shares Owned After: 9,691 | Ownership: D (Direct)
Footnotes:
[F1] The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
--- Footnotes (Complete Index) ---
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
--- Signature ---
/s/ /s/ Michael J. Rider, Global General Counsel and Secretary (2026-02-05)